MedTrace Logo

Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer

NCT06978322 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-05-22

No results posted yet for this study

Summary

This trial aimed to determine whether neoadjuvant chemoradiotherapy improves overall survival compared with upfront surgery, both followed by adjuvant chemotherapy in patients with resectable and borderline resectable pancreatic cancer.

Conditions

  • Surgery
  • Neoadjuvant Chemotherapy
  • Management
  • Resectable Pancreatic Cancer

Interventions

PROCEDURE

Immediate surgery

Patients will undergo upfront surgery, then adjuvant chemotherapy.

PROCEDURE

Neoadjuvant chemotherapy

Patients will undergo neoadjuvant chemotherapy, then surgery.

Sponsors & Collaborators

  • Minia University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2026-02-01
Completion
2026-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06978322 on ClinicalTrials.gov